Akoya Biosciences Inc (AKYA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 11,779 | 83,125 | 74,229 | 113,079 | 17,006 |
| Marketable Securities | 23,261 | 0 | 6,989 | N/A | N/A |
| Receivables | 13,779 | 16,994 | 9,729 | 9,444 | 6,470 |
| Inventories | 24,321 | 17,877 | 14,486 | 9,014 | 4,263 |
| TOTAL | $76,732 | $121,790 | $112,197 | $140,814 | $28,696 |
| Non-Current Assets | |||||
| PPE Net | 7,203 | 10,729 | 10,174 | 7,487 | 5,528 |
| Intangibles | 32,821 | 35,674 | 38,310 | 39,412 | 40,976 |
| Other Non-Current Assets | 8,249 | 12,176 | 15,350 | 3,194 | 2,460 |
| TOTAL | $48,273 | $58,579 | $63,834 | $50,093 | $48,964 |
| Total Assets | $125,005 | $180,369 | $176,031 | $190,907 | $77,660 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | N/A | 1,032 |
| Accounts payable and accrued liabilities | 8,759 | 11,776 | 10,628 | 9,435 | 5,074 |
| Accrued Expenses | 10,848 | 13,433 | 16,519 | 13,491 | 7,015 |
| TOTAL | $29,444 | $35,345 | $37,055 | $27,682 | $17,162 |
| Non-Current Liabilities | |||||
| Long Term Debt | 76,182 | 75,254 | 63,277 | 32,471 | 33,488 |
| Deferred Revenues | 6,554 | 6,688 | 6,279 | 4,484 | 3,844 |
| Other Non-Current Liabilities | 7,899 | 12,003 | 14,242 | 7,850 | 76,581 |
| TOTAL | $87,966 | $91,254 | $80,395 | $41,874 | $111,524 |
| Total Liabilities | $117,410 | $126,599 | $117,450 | $69,556 | $128,686 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 49,816 | 49,141 | 38,342 | 37,475 | N/A |
| Common Shares | 2 | 2 | 2 | 2 | 1 |
| Retained earnings | -285,436 | -230,071 | -166,748 | -96,107 | -52,280 |
| Other shareholders' equity | 7 | 0 | -6 | 0 | 1,253 |
| TOTAL | $7,595 | $53,770 | $58,581 | $121,351 | $-51,026 |
| Total Liabilities And Equity | $125,005 | $180,369 | $176,031 | $190,907 | $77,660 |